Prof. Dr. Michael Laxy
Academic Career and Research Areas
Prof Laxy (*1986) studies disease prevention in the context of public health and health care systems. His research concentrates on the analysis of determinates and consequences of chronic diseases as well as on the evaluation of prevention measures concerning their effectiveness, efficiency and distributional effects.
He studied sport science, public health, epidemiology and economics at TUM, the Ludwig-Maximilians University München (LMU) and the University of Hagen. After his PhD at LMU he lead a research unit at the Institute of Health Economics at the Helmholtz Zentrum München and did a Harkness Fellowship for Health Care Policy and Practice at the Centers of Disease Control and Prevention (CDC) in Atlanta. Since 2019 he is an adjunct professor at Emory University. In 2020 Prof. Laxy was appointed by TUM as professor for ‘Public Health and Prevention’.
Awards
- Presentation Award, International Diabetes Epidemiology Group Meeting, 2019
- DZD Award, German Center for Diabetes Research, 2019
- Young Investigator Award, American Diabetes Association, 2018
- HELENA Graduate Award for PhD thesis, Helmholtz Zentrum München, 2016
Key Publications (all publications)
Pedron, P., Kurz, CF., Schwettmann, L., Laxy, M.: “The Effect of BMI and Type 2 Diabetes on Socioeconomic Status: A Two-Sample Multivariable Mendelian Randomization Study”. Diabetes Care. 2021.
AbstractLaxy, M., Zhang, P., Ng, B., Shao, H., Ali, MK., Albright, A., Gregg E.: “Implementing Lifestyle Change Interventions to Prevent Type 2 Diabetes in US Medicaid Programs: Cost Effectiveness, and Cost, Health, and Health Equity Impact”. Applied Health Economics and Health Policy. 2020.
AbstractKurz, C. & Laxy, M.: “Application of Mendelian Randomization to Investigate the Association of Body Mass Index with Health Care Costs”. Medical Decision Making. 2020.
AbstractLaxy, M., Wilson, E., Boothby, C., Griffin, S.: “Incremental costs and cost-effectiveness of intensive treatment in patients with screen-detected type 2 diabetes in the ADDITION-UK trial: An update with empirical trial-based cost data”. Value in Health. 2017.
AbstractLaxy, M., Mielck, A., Hunger, M., Schunk, M., Meisinger, C., Rückert, I.M., Rathmann, W., Holle, R.: “The association between patient-reported self-management behavior, intermediate outcomes and mortality in type 2 diabetes patients: Results from the KORA-A study”. Diabetes Care. 2014; 37:1604-12.
Abstract